Allergic Rhinitis and its Impact on Asthma (ARIA)
暂无分享,去创建一个
[1] P. Nafstad. [Health effects of outdoor air pollution]. , 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[2] J. Bousquet,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .
[3] A. Chuchalin,et al. Prevention of allergy and asthma: interim report. , 2000 .
[4] A. Chuchalin,et al. Prevention of Allergy and Asthma Interim Report , 2000, Allergy.
[5] D. Enarson,et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] C. Bachert,et al. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. , 2000, Rhinology.
[7] J Bousquet,et al. Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.
[8] E. Meltzer,et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. , 2000, Pediatrics.
[9] G. Canonica,et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. , 2000, The Journal of allergy and clinical immunology.
[10] R. Bush,et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. , 1999, The New England journal of medicine.
[11] I. Cockburn,et al. Loss of work productivity due to illness and medical treatment. , 1999, Journal of occupational and environmental medicine.
[12] J. Warner. Primary sensitization in infants. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[13] D. Enarson,et al. Cultural barriers to asthma management , 1999, Pediatric pulmonology.
[14] R. Mösges,et al. International Conference on Allergic Rhinitis in Childhood , 1999 .
[15] F. Simons,et al. Allergic rhinobronchitis: the asthma-allergic rhinitis link. , 1999, The Journal of allergy and clinical immunology.
[16] S. Durham,et al. Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.
[17] J. Bousquet,et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. , 1999, The Journal of allergy and clinical immunology.
[18] B. Lipworth. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.
[19] O. V. van Schayck,et al. Control of house dust mite in managing asthma , 1999, BMJ.
[20] P. Gergen,et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. , 1999, The Journal of allergy and clinical immunology.
[21] J. Bousquet,et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. , 1999, American journal of respiratory and critical care medicine.
[22] M. Schatz. Interrelationships between asthma and pregnancy: a literature review. , 1999, The Journal of allergy and clinical immunology.
[23] B. Wüthrich,et al. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] D. Strachan,et al. Respiratory symptoms and home environment in children: a national survey , 1999, Thorax.
[25] B. Lipworth,et al. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids , 1999, Thorax.
[26] T. Casale. Pathogenic Factors and Therapeutic Options , 1999 .
[27] A. Leff. Immunobiology of Asthma and Rhinitis Pathogenic Factors and Therapeutic Options , 1999 .
[28] M. Burr,et al. Indoor air pollution and the respiratory health of children , 1999, Pediatric pulmonology. Supplement.
[29] C E Reed,et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. , 1999, The Journal of allergy and clinical immunology.
[30] M. Chapman,et al. Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong. , 1999, BMJ.
[31] I. Garrelds,et al. Nasal hyperreactivity. , 1999, Rhinology.
[32] R. Puy,et al. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials , 1998, BMJ.
[33] T. Platts-Mills,et al. Indoor versus outdoor allergens in allergic respiratory disease. , 1998, Current opinion in immunology.
[34] S. Fineman,et al. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[35] S. Spector,et al. Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[36] D. Strachan. House dust mite allergen avoidance in asthma , 1998, BMJ.
[37] P. Gøtzsche,et al. House dust mite control measures in the management of asthma: meta-analysis , 1998, BMJ.
[38] J Bousquet,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.
[39] B. Lipworth,et al. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. , 1998, The Journal of allergy and clinical immunology.
[40] A E Nel,et al. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. , 1998, The Journal of allergy and clinical immunology.
[41] J. Bousquet,et al. Local immunotherapy , 1998, Allergy.
[42] J. Bousquet,et al. Relationships between rhinitis and asthma , 1998, Allergy.
[43] K C Barnes,et al. The genetics and complexity of allergy and asthma. , 1998, Immunology today.
[44] B. Lundbäck,et al. Epidemiology of rhinitis and asthma. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[45] J. Balmes,et al. Subjects with seasonal allergic rhinitis and nonrhinitic subjects react differentially to nasal provocation with chlorine gas. , 1998, The Journal of allergy and clinical immunology.
[46] M. Andersson,et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. , 1998, The European respiratory journal.
[47] [WHO position paper. "Allergen immunotherapy: therapeutic vaccines for allergic diseases"]. , 1998, Arerugi = [Allergy].
[48] C. Mackay,et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.
[49] E. Minshall,et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. , 1997, American journal of respiratory cell and molecular biology.
[50] D. Strachan,et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[51] J. Bousquet,et al. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. , 1997, American journal of respiratory and critical care medicine.
[52] G. Canonica,et al. Treatment of allergic diseases during pregnancy. , 1997, Journal of investigational allergology & clinical immunology.
[53] D. Strachan,et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts , 1997, BMJ.
[54] R. Naclerio. Pathophysiology of perennial allergic rhinitis , 1997, Allergy.
[55] C. Lemière,et al. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. , 1997, The European respiratory journal.
[56] S. Lau,et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. , 1997, The Journal of allergy and clinical immunology.
[57] J. Bousquet,et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. , 1997, The Journal of allergy and clinical immunology.
[58] N. Roche,et al. Allergic and nonallergic interactions between house dust mite allergens and airway mucosa. , 1997, The European respiratory journal.
[59] J. Corren. Allergic rhinitis and asthma: how important is the link? , 1997, The Journal of allergy and clinical immunology.
[60] D. Malone,et al. A cost of illness study of allergic rhinitis in the United States. , 1997, The Journal of allergy and clinical immunology.
[61] Pertti Mutanen,et al. The risk of occupational rhinitis , 1997, International archives of occupational and environmental health.
[62] G. Lewith,et al. Unconventional therapies in asthma: an overview , 1996, Allergy.
[63] P. Norman. Is there a role for immunotherapy in the treatment of asthma? Yes. , 1996, American journal of respiratory and critical care medicine.
[64] D. Edelstein. Aging of the Normal Nose in Adults , 1996, The Laryngoscope.
[65] A. Foresi,et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. , 1996, The Journal of allergy and clinical immunology.
[66] A. Saxon,et al. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. , 1996, The Journal of allergy and clinical immunology.
[67] Simons Fe. Learning impairment and allergic rhinitis. , 1996 .
[68] J. Bousquet,et al. Pathophysiology of allergic rhinitis. , 1996, International archives of allergy and immunology.
[69] F. Simons. Learning impairment and allergic rhinitis. , 1996, Allergy and asthma proceedings.
[70] P. Barnes. Is there a role for immunotherapy in the treatment of asthma? No. , 1996, American journal of respiratory and critical care medicine.
[71] Deborah Jarvis,et al. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). , 1996, The European respiratory journal.
[72] R. Pawankar,et al. Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis. , 1995, American journal of respiratory and critical care medicine.
[73] G. Canonica,et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. , 1995, The Journal of allergy and clinical immunology.
[74] G. Canonica,et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. , 1995, International archives of allergy and immunology.
[75] C. Prescott,et al. Peak nasal inspiratory flow measurement: an investigation in children. , 1995, International journal of pediatric otorhinolaryngology.
[76] U Ackermann-Liebrich,et al. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. , 1995, International archives of allergy and immunology.
[77] A. Jones,et al. The limitations of peak nasal flow measurement. , 1994, Clinical otolaryngology and allied sciences.
[78] W. Morgan,et al. Epidemiology of physician-diagnosed allergic rhinitis in childhood. , 1994, Pediatrics.
[79] J. Bousquet,et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. , 1994, The Journal of allergy and clinical immunology.
[80] F. Simons,et al. The pharmacology and use of H1-receptor-antagonist drugs. , 1994, The New England journal of medicine.
[81] P. Howarth,et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. , 1994, American journal of respiratory cell and molecular biology.
[82] N. M. Kjellman,et al. Natural course of asthma and allergy in childhood , 1994, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[83] J. Neher,et al. Health effects of outdoor air pollution. , 1994, American family physician.
[84] U Keil,et al. Self-reported wheezing and allergic rhinitis in children and traffic density on street of residence. , 1994, Annals of epidemiology.
[85] P. Howarth,et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. , 1993, Journal of immunology.
[86] J. Bousquet,et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. , 1993, The American review of respiratory disease.
[87] P. Howarth,et al. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. , 1993, The European respiratory journal.
[88] W. Busse,et al. Increased airway inflammation with segmental versus aerosol antigen challenge. , 1993, The American review of respiratory disease.
[89] Julia Brasch,et al. Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .
[90] F. Simons,et al. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. , 1993, The Journal of allergy and clinical immunology.
[91] J. Bousquet,et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. , 1992, The Journal of allergy and clinical immunology.
[92] P. Turkeltaub,et al. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). , 1992, The Journal of allergy and clinical immunology.
[93] E. Pastorello,et al. Clinical evaluation of CAP System and RAST in the measurement of specific IgE , 1992, Allergy.
[94] W. Fokkens,et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non‐allergic controls: a biopsy study , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[95] S. Durham,et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. , 1992, Journal of immunology.
[96] S. Durham,et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. , 1992, The Journal of allergy and clinical immunology.
[97] C. Irvin,et al. Changes in bronchial responsiveness following nasal provocation with allergen. , 1992, The Journal of allergy and clinical immunology.
[98] L. Calderón-Garcidueñas,et al. Histopathologic changes of the nasal mucosa in southwest Metropolitan Mexico City inhabitants. , 1992, The American journal of pathology.
[99] J. Dry,et al. Allergy to latex , 1991, Clinical reviews in allergy.
[100] B. Sibbald,et al. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. , 1991, Thorax.
[101] F. Neukirch,et al. Protective effect of theophylline on bronchial hyperresponsiveness in patients with allergic rhinitis. , 1991, The American review of respiratory disease.
[102] G. Guyatt,et al. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[103] M. Iversen,et al. Epidemiology of house dust mite allergy , 1991, Allergy.
[104] P. Turkeltaub,et al. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). , 1991, Annals of allergy.
[105] G. Scadding,et al. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. , 1990, Rhinology.
[106] R. Dahl,et al. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma , 1990, Allergy.
[107] J. Bousquet,et al. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. , 1990, The Journal of allergy and clinical immunology.
[108] N. Eriksson,et al. Allergy screening with Phadiatop and CAP Phadiatop in combination with a questionnaire in adults with asthma and rhinitis. , 1990, Allergy.
[109] M. Bende,et al. Nasal congestion during pregnancy. , 1989, Clinical otolaryngology and allied sciences.
[110] U. Pipkorn,et al. Nasal mucosal blood flow after intranasal allergen challenge. , 1988, The Journal of allergy and clinical immunology.
[111] U. Pipkorn,et al. Hay fever: in the laboratory and at natural allergen exposure , 1988, Allergy.
[112] U. Ryo,et al. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. , 1975, The Journal of allergy and clinical immunology.